Degnan Chris 4
4 · Galera Therapeutics, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-25+185,000→ 185,000 totalExercise: $1.78Exp: 2033-02-24→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023.